Meningococcal Conjugates Vaccine - Biotech, Pharma and Life Science Channel

02:42 EDT 23rd October 2014 | BioPortfolio

PubMed Articles [1799 Associated PubMed Articles listed on BioPortfolio]

Determination of α- and β-boldenone sulfate, glucuronide and free forms, and androstadienedione in bovine urine using immunoaffinity columns clean-up and liquid chromatography tandem mass spectrometry analysis.

The debate about the origins of boldenone in bovine urine is ongoing for two decades in Europe. Despite the fact that its use as a growth promoter has been banned in the European Union (EU) since 1981...

Hepatitis B in Pregnancy.

Hepatitis B Virus (HBV) infects over 2 billion people worldwide, with approximately 360 million chronically infected. It results in substantial morbidity and mortality, with an estimated 600,000 death...

Disease Surveillance Methods Used in the 8-Site MAL-ED Cohort Study.

Describing the early life associations between infectious disease episodes and growth, cognitive development, and vaccine response in the first 2 years of life is one of the primary goals of the Etiol...

Methods of Analysis of Enteropathogen Infection in the MAL-ED Cohort Study.

Studies of diarrheal etiology in low- and middle-income countries have typically focused on children presenting with severe symptoms to health centers and thus are best equipped to describe the pathog...

Assessment of Environmental Enteropathy in the MAL-ED Cohort Study: Theoretical and Analytic Framework.

Individuals in the developing world live in conditions of intense exposure to enteric pathogens due to suboptimal water and sanitation. These environmental conditions lead to alterations in intestinal...

Evaluating Associations Between Vaccine Response and Malnutrition, Gut Function, and Enteric Infections in the MAL-ED Cohort Study: Methods and Challenges.

Most vaccine assessments have occurred in well-nourished populations of higher socioeconomic status. However, vaccines are often used in populations with high incidences of malnutrition and infections...

Bhaktapur, Nepal: The MAL-ED Birth Cohort Study in Nepal.

The Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED) cohort study site in Nepal is located in the Bhaktapur...

Support for HPV Vaccination Mandates for Both Females and Males.

To examine college students' support for HPV vaccination mandates for school-aged youth and examine perceptions and behavioral factors associated with vaccine mandate support for both boys and girls.

The Estimated Impact of Human Papillomavirus Vaccine Coverage on the Lifetime Cervical Cancer Burden Among Girls Currently Aged 12 Years and Younger in the United States.

Using a previously published dynamic model, we illustrate the potential benefits of human papillomavirus vaccination among girls currently 12 years or younger in the United States. Increasing vaccine ...

Ultrastructure of spermatozoa of orsolobidae (Haplogynae, Araneae) with implications on the evolution of sperm transfer forms in Dysderoidea.

Cover illustration. Haplogynae are highly diverse group of spiders with respect to the primary male genital system and sperm characteristics. Within this group, different sperm transfer forms evolved,...

News Articles [2617 Associated News Articles listed on BioPortfolio]

Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN® for Additional Infectious Disease Targets

KVISTGAARD, Denmark, October 22, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that it has agreed with Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of ...

Johnson & Johnson announces major commitment to expedite ebola vaccine development

Johnson & Johnson (JNJ) has made a commitment of up to $200m to accelerate and significantly expand the production of an Ebola vaccine program in development at its Janssen Pharmaceutical Companies.

TapImmune provides update on PolyStart vaccine platform applicable to cancer and infectious disease

TapImmune (TPIV), provides an update on the status of its PolyStartTM vaccine technology platform in light of recent global concerns regarding pandemic infections and emerging viral threats such as Eb...

Zymeworks Inc. Announces over-Subscription of Previously Announced Private Placement in Conjunction with the Expansion of a Strategic Collaboration

Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the c...

Vaccines: The End of Illness Overview, Cambridge Healthtech Advisors

LONDON, Oct. 22, 2014 /PRNewswire/ -- This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their low cost, extended prote...

UPDATE 6-Drugmakers to join forces to make millions of Ebola vaccine doses

* GlaxoSmithKline sees first vaccine doses ready this year

NIH Begins Early Human Clinical Trial of New Ebola Vaccine

Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland.Read more about NIH Begins Early Human Cli...

Human medicines European public assessment report (EPAR): ProQuad, measles, mumps, rubella and varicella vaccine (live), Revision: 16, Authorised

UPDATE 5-Drugmakers to join forces to make millions of Ebola vaccine doses

* GlaxoSmithKline sees first vaccine doses ready this year

Janssen's Crucell Holland gets license to Ebola vaccine candidate from Bavarian Nordic

Danish vaccines firm Bavarian Nordic AS licensed Janssen Pharmaceutical Cos.’s Crucell Holland BV exclusive worldwide rights to its multivalent MVA-BN Filovirus vaccine candidate for the Zaire and S...

Events [0 Results]

None

Companies [98 Associated Companies listed on BioPortfolio]

Mucosis B.V.

Mucosis B.V. (Mucosis) is a clinical-stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious disea...

The Vaccine & Gene Therapy Institute of Florida

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

ADC Therapeutics

ADC Therapeutics sarl (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major ...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied fo...

Igenica Biotherapeutics, Inc.

Igenica Biotherapeutics is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only biotherapeut...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue...

Redbiotec

Redbiotec is a privately held Swiss biopharmaceutical company founded in 2006 and based in Zurich-Schlieren. The company uses its proprietary rePAX® co-expression tec...

Biosceptre

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs di...

Igenica Biotherapeutics

Igenica Biotherapeutics is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only biotherapeut...

Clinical Trials [2056 Associated Clinical Trials listed on BioPortfolio]

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Background: - Many cancers produce two proteins, carcinoembryonic antigen (CEA) and mucin-1 (MUC-1). - The PANVAC-V priming vaccine and PANVAC-F boosting vaccine contain human gene...

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

A study in two parts (Part A and Part B) to evaluate the responsiveness of various biomarkers of immunity to Varicella-Zoster Virus (VZV) following repeated immunizations with heat treated...

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

This randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be removed by ...

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

The purpose of this trial is to demonstrate the acceptable safety profile and the immunological non-inferiority of the FLU D-QIV vaccine manufactured with this investigational process (FLU...

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' HZ/su vaccine in subjects' ≥ 50 years of age (YOA) who previously have had Herpes Zoster (HZ). ...

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

This randomized phase I trial studies the side effects and best way to give vaccine therapy together with basiliximab in treating patients with acute myeloid leukemia (AML) in complete rem...

Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

The purpose of this study is to collect safety information following routine vaccination with Synflorix™ among infants in Korea.

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

Background: - Seasonal influenza is a major health problem whose impact is typically reduced by vaccination. The H1N1 (swine flu) influenza virus is an emerging pathogen that has the ...

Kinetics of B Cell Response in Infants Menjugate Vaccination

Kinetics of B cell response in infants Menjugate vaccination

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

The purpose of this study is to demonstrate the non-inferiority of the candidate Hib-MenC conjugate vaccine co-administered with Infanrix™-IPV versus a licensed meningococcal serogroup C...

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Meningococcal Conjugates Vaccine market research data and corporate reports here

Channels Quicklinks